Healthcare provider profile · identity verified

David C Kay, M.D.

Internal Medicine · GOSHEN, IN · NPI 1073586335

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	651	185
Amlodipine Besylate	Amlodipine Besylate	646	184
Lisinopril	Lisinopril	490	141
Levothyroxine Sodium	Levothyroxine Sodium	439	121
Metformin Hcl	Metformin Hcl	390	105
Gabapentin	Gabapentin	310	84
Rosuvastatin Calcium	Rosuvastatin Calcium	285	95
Simvastatin	Simvastatin	273	78
Omeprazole	Omeprazole	257	79
Metoprolol Succinate	Metoprolol Succinate	256	74
Hydrochlorothiazide	Hydrochlorothiazide	252	70
Tamsulosin Hcl	Tamsulosin Hcl	249	76
Furosemide	Furosemide	239	76
Pantoprazole Sodium	Pantoprazole Sodium	200	53
Sertraline Hcl	Sertraline Hcl	195	43
Eliquis	Apixaban	190	38
Metoprolol Tartrate	Metoprolol Tartrate	170	52
Losartan Potassium	Losartan Potassium	168	57
Potassium Chloride	Potassium Chloride	160	46
Clopidogrel	Clopidogrel Bisulfate	140	46
Albuterol Sulfate Hfa	Albuterol Sulfate	127	53
Carvedilol	Carvedilol	120	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	119	33
Meloxicam	Meloxicam	118	38
Irbesartan	Irbesartan	111	35
Glipizide	Glipizide	108	32
Alendronate Sodium	Alendronate Sodium	102	33
Allopurinol	Allopurinol	100	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	96	29
Escitalopram Oxalate	Escitalopram Oxalate	94	19
Pravastatin Sodium	Pravastatin Sodium	93	27
Alprazolam	Alprazolam	89	20
Shingrix	Varicella-Zoster Ge/As01b/Pf	85	67
Clonazepam	Clonazepam	84	12
Warfarin Sodium	Warfarin Sodium	84	19
Ropinirole Hcl	Ropinirole Hcl	82	16
Hydralazine Hcl	Hydralazine Hcl	80	19
Tramadol Hcl	Tramadol Hcl	80	21
Zolpidem Tartrate	Zolpidem Tartrate	79	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	75	26
Ozempic	Semaglutide	71	15
Citalopram Hbr	Citalopram Hydrobromide	70	17
Glipizide Er	Glipizide	68	20
Jardiance	Empagliflozin	67	16
Montelukast Sodium	Montelukast Sodium	67	26
Trazodone Hcl	Trazodone Hcl	67	19
Januvia	Sitagliptin Phosphate	66	18
Synthroid	Levothyroxine Sodium	66	18
Glimepiride	Glimepiride	65	15
Chlorthalidone	Chlorthalidone	59	18
Famotidine	Famotidine	57	20
Finasteride	Finasteride	57	18
Venlafaxine Hcl Er	Venlafaxine Hcl	56	14
Atenolol	Atenolol	53	16
Duloxetine Hcl	Duloxetine Hcl	52	20
Nifedipine Er	Nifedipine	52	13
Donepezil Hcl	Donepezil Hcl	51	11
Doxycycline Hyclate	Doxycycline Hyclate	51	39
Prednisone	Prednisone	50	23
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	49	49
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	15
Benazepril Hcl	Benazepril Hcl	46	15
Metformin Hcl Er	Metformin Hcl	46	15
Ezetimibe	Ezetimibe	44	14
Fluoxetine Hcl	Fluoxetine Hcl	44	14
Memantine Hcl	Memantine Hcl	44	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	32
Pioglitazone Hcl	Pioglitazone Hcl	42	11
Diazepam	Diazepam	41	suppressed
Valsartan	Valsartan	41	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	16
Spironolactone	Spironolactone	38	suppressed
Pregabalin	Pregabalin	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	11
Meclizine Hcl	Meclizine Hcl	36	13
Fluticasone Propionate	Fluticasone Propionate	35	16
Ramipril	Ramipril	35	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	14
Mirtazapine	Mirtazapine	34	suppressed
Torsemide	Torsemide	34	suppressed
Amoxicillin	Amoxicillin	32	20
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Gemfibrozil	Gemfibrozil	30	suppressed
Lovastatin	Lovastatin	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Cephalexin	Cephalexin	25	19
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	24	suppressed
Ranolazine Er	Ranolazine	24	suppressed
Digoxin	Digoxin	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	20
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Lorazepam	Lorazepam	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	20	20
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Xarelto	Rivaroxaban	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	14
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Nitroglycerin	Nitroglycerin	17	15
Novolog Flexpen	Insulin Aspart	17	suppressed
Temazepam	Temazepam	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Repatha Sureclick	Evolocumab	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Nystatin	Nystatin	13	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Lagevrio (Eua)	Molnupiravir	12	12
Metronidazole	Metronidazole	12	suppressed
Naproxen	Naproxen	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Azithromycin	Azithromycin	11	11
Bumetanide	Bumetanide	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Propafenone Hcl	Propafenone Hcl	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error